BACK TO TOP

Who We Are

Our Services

  /  Our Services

ClinTrial Networks Services

Matching quality sites with CRO and Sponsor projects is what CTN does best thus saving time and money for the CDA and FQ process.

CTN is not an SMO and all CROs and Sponsors contract directly with investigative sites for startup activities. Patient recruitment and retention is a key bottle neck in the Industry so our trial centers have spent years building their database for patients that are research naïve. We also represent large minority group patients that don’t have access to healthcare coverage.

We also have the ability to help large minority groups who don’t have access to healthcare coverage. We have Urgent Care Centers across the USA who provide research coverage and or treatment options to those who don’t have medical insurance.

ClinTrialNetworks and Rosenbaum Group Join in Major Expansion

ClinTrialNetworks are proudly announcing partnership with Rosenbaum Group in April 2025.

ClinTrialNetworks as focusing group of independently owned investigator sites in Americas, Australias and Europe continents are expanding the portfolio of services offered by Rosenbaum Group in southern Europe covering Albania, Bulgaria, Cyprus, Denmark, Greece, Macedonia, Moldova, Slovakia and Turkey.

Rosenbaum Group is providing full service and end to end solutions for Pharma companies and CROs covering all indications and therapeutic areas. Rosenbaum Group in addition is offering global feasibility-proposal support, business development and operational excellence to research sites/site networks in the Baltic countries in Europe. With more than 5 years of CRO experience and fast-growing country coverage, including regulatory, monitoring, import/export licensing, patient access and contracting services, brings Rosenbaum Group great potential to ClinTrialNetworks portfolio of services. Rosenbaum Group as strategically positioned CRO in Baltics, brings expansion of countries and additional services for ClinTrialNetworks.

The partnership of both companies is transformational moment with the main focus to enlarge the footprint in Europe and also to expand the coverage of services provided to clients by both companies. The partnership brings deep knowledge and experience in the sector and expansion of relationships of investigator sites in Baltic countries with the end to end CRO services for clients.

References:

Rosenbaum Group: https://rosenbaum-group.com/research/ Author: David Rosenbaum, CEO

ClinTrialNetworks: https://clintrialnetworks.com/ Brian K. Norton, Director

Address

109 Clifton Downs Road
Herron Western Australia 6211

Phone

+614 884 04412

Cell

+614 884 04412

Fax

+614 884 04412

ClinTrial Networks consists of a group of independently owned investigator sites located throughout the United States and Asia Pacific, however we are not an SMO. Sites complete their own CDA’s Feasibility Questionnaires and regulatory documents. Each site has extensive research experience and conduct studies across a broad range of therapeutic areas.

Copyright © 2010 ClinTrial Networks — All rights reserved.